Search Results
Bevacizumab in Mesothelioma
Improved Survival in Malignant Pleural Mesothelioma with Avastin Added to Chemotherapy
BEAT-meso: Phase III trial of bevacizumab and chemo ± atezolizumab for advanced pleural mesothelioma
Therapeutic targets for mesothelioma and sarcomatoid carcinoma
The Survival Benefit with Avastin Added to Chemotherapy
Targeting the tumor vasculature in mesothelioma
Charles Fuchs, MD: Experience With Patients on Bevacizumab Plus Chemotherapy
Discussion of the results from the BEAT-meso trial in pleural mesothelioma
Systemic Therapies for Mesothelioma | International Symposium on Malignant Mesothelioma
MesoTV | NOW ENROLLING: Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Case 1: Bevacizumab in Stage IV Ovarian Cancer
MesoTV | Results from phase 2 peritoneal mesothelioma trial w/ combination therapy (VEGF and immuno)
